Li Kang Biomedical Co., Ltd.

6242

TW0006242001

Food Processing

End-of-day quote Taipei Exchange Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
50.8 ^TWD	+1.60%		+1.80%	-12.86%

05-10	Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-13	Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

BAFO Technologies Corp. cancelled the transaction announced on September 10, 2013

April 28, 2015

On April 29, 2015, LI KANG BIOMEDICAL CO., LTD. cancelled the transaction.

Latest news about Li Kang Biomedical Co., Ltd.

Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/08/23	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/03/23	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	08/08/22	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	06/05/22	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	10/03/22	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08/11/21	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	05/08/21	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/05/21	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	07/03/21	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	08/11/20	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	09/08/20	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	06/05/20	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	11/03/20	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019	06/11/19	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019	05/08/19	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	07/05/19	CI
Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	11/03/19	CI
Bafo Technologies Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	07/11/18	CI
BAFO Technologies Corp. cancelled the transaction announced on September 10, 2013	28/04/15	CI
BAFO Technologies Corp. announced a financing transaction.	10/09/13	CI

Chart Li Kang Biomedical Co., Ltd.

Duration

Period

More charts

Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.

Sector

Food Processing

Calendar

05/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
LI KANG BIOMEDICAL CO., LTD.	-12.86%	49.74M
ZHEJIANG NHU COMPANY LTD.	+13.21%	8.12B
BELLRING BRANDS, INC.	+4.64%	7.45B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-17.32%	4.88B
THE SIMPLY GOOD FOODS COMPANY	-8.76%	3.62B
BYHEALTH CO., LTD	-20.43%	3.17B
XIAMEN KINGDOMWAY GROUP COMPANY	-11.51%	1.21B
HERBALIFE LTD.	-31.91%	1.04B
JAMIESON WELLNESS INC.	-8.57%	879M
USANA HEALTH SCIENCES, INC.	-15.60%	862M